Elixir Pharmaceuticals To Present At Biotechnology Industry Organization (BIO) CEO And Investor Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elixir Pharmaceuticals announced today that William Heiden, President and Chief Executive Officer, is scheduled to participate in a panel discussion and to present a corporate update at the BIO CEO and Investor Conference at The Waldorf=Astoria Hotel in New York, NY. The company presentation will take place in the hotel’s Park Avenue Suite on Wednesday, February 14 at 11:15am. Mr. Heiden will also participate in the conference workshop entitled, "Baby Boomers - Where Are the Growth Market Opportunities?," which is scheduled for Wednesday, February 14 at 9:00 am in the Waldorf’s Jade Room.